
Stevanato Group Investor Relations Material
Latest events

Q1 2025
Stevanato Group
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Stevanato Group S.p.A.
Access all reports
Stevanato Group S.p.A. is a global provider of containment, delivery, and diagnostic solutions for the pharmaceutical, biotechnology, and life sciences industries. The company specializes in the production of glass containers, such as vials, syringes, and cartridges, used for drug storage and delivery. In addition to its core manufacturing services, Stevanato offers integrated solutions that include drug delivery systems, assembly equipment, and analytical testing. Its products support a range of applications, including injectable drugs, biologics, and diagnostics, helping ensure the safe and effective administration of treatments. The company is headquartered in Piombino Dese, Italy, and its shares are listed on the NYSE.
Key slides for Stevanato Group S.p.A.


Q1 2025
Stevanato Group S.p.A.


Q1 2025
Stevanato Group S.p.A.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
STVN
Country
🇺🇸 United States